Back

Genomic, transcriptomic, and metabolomic analysis of Traditional Chinese Medicine plant Oldenlandia corymbosa reveals the biosynthesis and mode of action of anti-cancer metabolites

Julca, I.; Mutwil-Anderwald, D.; Manoj, V.; Khan, Z.; Lai, S. K.; Yang, L. K.; Beh, I. T.; Dziekan, J.; Lim, Y. P.; Lim, S. K.; Low, Y. W.; Lam, Y. I.; Mu, Y.; Tan, Q. W.; Nuc, P.; Choo, L. M.; Khew, G.; Loo, S.; Kam, A.; Tam, J. P.; Bozdech, Z.; Schmidt, M.; Usadel, B.; Kanagasundaram, Y. S.; Alseekh, S.; Fernie, A. R.; Li, H. Y.; Mutwil, M.

2022-06-15 plant biology
10.1101/2022.06.14.496066 bioRxiv
Show abstract

Natural products from traditional medicinal plants are valuable candidates for clinical cancer therapy. Plants from the Oldenlandia-Hedyotis complex are popular ingredients of Traditional Chinese Medicine (TCM), however a major hurdle in the plant bioprospecting process of TCM plants is that the active metabolites, their biosynthetic pathways, and mode of action are often unknown. We show that Oldenlandia corymbosa extracts are active against breast cancer cell lines. To study the genes involved in the biosynthesis of active compounds in this medicinal plant, we assembled a high-quality genome. We show that the main active compound is ursolic acid and that abiotic stresses cause changes in anti-cancer activity, metabolite composition, and gene expression of plants. To reveal the mode of action of ursolic acid, we show that cancer cells undergo mitotic catastrophe, and we identify three high-confidence protein binding targets by Cellular Thermal Shift Assay (CETSA) and reverse docking.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.